Author Details

Agulnik, J., Peter Brojde Lung Cancer Center, Canada

  • Vol 22, No 3 (2015) - Medical Oncology
    An exploratory comparative analysis of tyrosine kinase inhibitors or docetaxel in second-line treatment of EGFR wild-type non-small-cell lung cancer: a retrospective real-world practice review at a single tertiary care centre
    Abstract  PDF  HTML